Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Interest & Investment Income: 2017-2024

Historic Interest & Investment Income for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $4.7 million.

  • Puma Biotechnology's Interest & Investment Income fell 18.56% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 2.61%. This contributed to the annual value of $4.7 million for FY2024, which is 81.34% up from last year.
  • As of FY2024, Puma Biotechnology's Interest & Investment Income stood at $4.7 million, which was up 81.34% from $2.6 million recorded in FY2023.
  • Puma Biotechnology's Interest & Investment Income's 5-year high stood at $4.7 million during FY2024, with a 5-year trough of $160,000 in FY2021.
  • Its 3-year average for Interest & Investment Income is $2.7 million, with a median of $2.6 million in 2023.
  • As far as peak fluctuations go, Puma Biotechnology's Interest & Investment Income tumbled by 82.82% in 2020, and later spiked by 408.12% in 2022.
  • Over the past 5 years, Puma Biotechnology's Interest & Investment Income (Yearly) stood at $489,000 in 2020, then tumbled by 67.28% to $160,000 in 2021, then spiked by 408.12% to $813,000 in 2022, then soared by 220.42% to $2.6 million in 2023, then spiked by 81.34% to $4.7 million in 2024.